Urologic Oncology: Seminars and Original Investigations
Volume 25, Issue 2 , Pages 141-146 , March 2007

Testis-specific protein Y-encoded gene is expressed in early and late stages of gonadoblastoma and testicular carcinoma in situ

  • Yunmin Li, Ph.D.

      Affiliations

    • Department of Medicine, VA Medical Center, University of California, San Francisco, CA 94121, USA
  • ,
  • Eric Vilain, M.D.

      Affiliations

    • Department of Human Genetics, University of California, Los Angeles, CA 90095-7088, USA
  • ,
  • Felix Conte, M.D.

      Affiliations

    • Department of Pediatrics, University of California, San Francisco, CA 94143-0136, USA
  • ,
  • Ewa Rajpert-De Meyts, M.D., Ph.D.

      Affiliations

    • Department of Growth and Reproduction, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark
  • ,
  • Yun-Fai Chris Lau, Ph.D.

      Affiliations

    • Department of Medicine, VA Medical Center, University of California, San Francisco, CA 94121, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-415-379-5526; fax: +1-415-750-6633.

Received 31 March 2006 ,Revised 31 July 2006 ,Accepted 1 August 2006.

References 

  1. Scully RE. Gonadoblastoma; a gonadal tumor related to the dysgerminoma (seminoma) and capable of sex-hormone production. Cancer. 1953;6:455–463
  2. Scully RE. Gonadoblastoma (A review of 74 cases). Cancer. 1970;25:1340–1356
  3. Verp MS, Simpson JL. Abnormal sexual differentiation and neoplasia. Cancer Genet Cytogenet. 1987;25:191–218
  4. Gravholt CH, Fedder J, Naeraa RW, et al. Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: A population study. J Clin Endocrinol Metab. 2000;85:3199–3202
  5. Mancilla EE, Poggi H, Repetto G, et al. Y chromosome sequences in Turner’s syndrome: Association with virilization and gonadoblastoma. J Pediatr Endocrinol Metab. 2003;16:1157–1163
  6. Mazzanti L, Cicognani A, Baldazzi L, et al. Gonadoblastoma in Turner syndrome and Y-chromosome-derived material. Am J Med Genet A. 2005;135:150–154
  7. Kersemaekers AM, Honecker F, Stoop H, et al. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma. Hum Pathol. 2005;36:512–521
  8. Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer. 2005;5:210–222
  9. Page DC. Hypothesis: A Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development. 1987;101(Suppl):151–155
  10. Lau YF. Gonadoblastoma, testicular and prostate cancers, and the TSPY gene. Am J Hum Genet. 1999;64:921–927
  11. Tsuchiya K, Reijo R, Page DC, et al. Gonadoblastoma: Molecular definition of the susceptibility region on the Y chromosome. Am J Hum Genet. 1995;57:1400–1407
  12. Salo P, Kaariainen H, Petrovic V, et al. Molecular mapping of the putative gonadoblastoma locus on the Y chromosome. Genes Chromosomes Cancer. 1995;14:210–214
  13. Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature. 2003;423:825–837
  14. Lau YF, Zhang J. Expression analysis of thirty one Y chromosome genes in human prostate cancer. Mol Carcinog. 2000;27:308–321
  15. Hildenbrand R, Schroder W, Brude E, et al. Detection of TSPY protein in a unilateral microscopic gonadoblastoma of a Turner mosaic patient with a Y-derived marker chromosome. J Pathol. 1999;189:623–626
  16. Jordan BK, Jain M, Natarajan S, et al. Familial mutation in the testis-determining gene SRY shared by an XY female and her normal father. J Clin Endocrinol Metab. 2002;87:3428–3432
  17. Hoei-Hansen CE, Nielsen JE, Almstrup K, et al. Identification of genes differentially expressed in testes containing carcinoma in situ. Mol Hum Reprod. 2004;10:423–431
  18. Hoei-Hansen CE, Nielsen JE, Almstrup K, et al. Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. Clin Cancer Res. 2004;10:8521–8530
  19. Kido T, Lau YF. A Cre gene directed by a human TSPY promoter is specific for germ cells and neurons. Genesis. 2005;42:263–275
  20. Oh HJ, Li Y, Lau YF. Sry associates with the heterochromatin protein 1 complex by interacting with a KRAB domain protein. Biol Reprod. 2005;72:407–415
  21. Honecker F, Stoop H, de Krijger RR, et al. Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol. 2004;203:849–857
  22. Zhang JS, Yang-Feng TL, Muller U, et al. Molecular isolation and characterization of an expressed gene from the human Y chromosome. Hum Mol Genet. 1992;1:717–726
  23. Rajpert-De Meyts E, Hanstein R, Jorgensen N, et al. Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. Hum Reprod. 2004;19:1338–1344
  24. Hoei-Hansen CE, Rajpert-De Meyts E, Daugaard G, et al. Carcinoma in situ testis, the progenitor of testicular germ cell tumours: A clinical review. Ann Oncol. 2005;16:863–868
  25. Jorgensen N, Muller J, Jaubert F, et al. Heterogeneity of gonadoblastoma germ cells: Similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells. Histopathology. 1997;30:177–186
  26. Rajpert-De Meyts E, Bartkova J, Samson M, et al. The emerging phenotype of the testicular carcinoma in situ germ cell. APMIS. 2003;111:267–278
  27. Rorth M, Rajpert-De Meyts E, Andersson L, et al. Carcinoma in situ in the testis. Scand J Urol Nephrol Suppl. 2000;205:166–186
  28. Schnieders F, Dork T, Arnemann J, et al. Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet. 1996;5:1801–1807
  29. Sinclair AH, Berta P, Palmer MS, et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature. 1990;346:240–244
  30. Berta P, Hawkins JR, Sinclair AH, et al. Genetic evidence equating SRY and the testis-determining factor. Nature. 1990;348:448–450
  31. Koopman P, Gubbay J, Vivian N, et al. Male development of chromosomally female mice transgenic for Sry. Nature. 1991;351:117–121
  32. Vogt PH. AZF deletions and Y chromosomal haplogroups: History and update based on sequence. Hum Reprod Update. 2005;11:319–336
  33. Lau YF, Lau HW, Komuves LG. Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer. Cytogenet Genome Res 200;101:250–60.
  34. Adachi Y, Pavlakis GN, Copeland TD. Identification and characterization of SET, a nuclear phosphoprotein encoded by the translocation break point in acute undifferentiated leukemia. J Biol Chem. 1994;269:2258–2262
  35. Vogel T, Dittrich O, Mehraein Y, et al. Murine and human TSPYL genes: Novel members of the TSPY-SET-NAP1L1 family. Cytogenet Cell Genet. 1998;81:265–270
  36. Ozbun LL, You L, Kiang S, et al. Identification of differentially expressed nucleolar TGF-beta1 target (DENTT) in human lung cancer cells that is a new member of the TSPY/SET/NAP-1 superfamily. Genomics. 2001;73:179–193
  37. Chai Z, Sarcevic B, Mawson A, et al. SET-related cell division autoantigen-1 (CDA1) arrests cell growth. J Biol Chem. 2001;276:33665–33674
  38. Canela N, Rodriguez-Vilarrupla A, Estanyol JM, et al. The SET protein regulates G2/M transition by modulating cyclin B-cyclin-dependent kinase 1 activity. J Biol Chem. 2003;278:1158–1164

 This work was partially supported by research grants from the National Institutes of Health, the Department of Defense Research Program on Prostate Cancer, and the VA Merit Research Program (Y.-F.C.L). Dr. Lau is a Research Career Scientist of the Department of Veterans Affairs.

PII: S1078-1439(06)00166-9

doi: 10.1016/j.urolonc.2006.08.002

Urologic Oncology: Seminars and Original Investigations
Volume 25, Issue 2 , Pages 141-146 , March 2007